U.S. lobby group slams drug trade with Canada
AIMS' recent report, "Drug Re-Importation in North America and Europe: An Overview" is getting noticed on both sides of the Canada-U.S. border. The report, written by Brian Ferguson, AIMS Fellow in Health Care Economics, elicited the Pharmaceutical Research and Manufacturers of America to issue a statement warning Americans that foreign drugs aren't safe. AIMS Director of Research Ian Munro goes on to note that such plans may have an impact on the drug supply in Canada and cause shortages.